Summary of Product Characteristics
last updated on the eMC:
19/02/2010
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 19/02/2010 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 1 -Name of the Medicinal product
-
Change to section 6. 3 - Shelf Life
-
Change to section 7 - Marketing Authorisation Holder
-
Change to MA holder contact details
|
| Date of revision of text on the SPC: 11-Jun-2008 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
|
· Change in name of product in the UK - Amlodipine to Amlostin 09/06/04
· Change in name of MAH in the UK (SPUK to Genus Pharmaceuticals Ltd) 12/04/05
· Shelf life extension - 24 mths to 36 mths 26/06/06
· Change to address for UK MAH Genus Pharmaceuticals 13/06/2008
|
|
Updated on 22/09/2004 and displayed until 19/02/2010
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
|